Detection/NN
of/IN
minimal/JJ
residual/JJ
disease/NN
in/IN
a/DT
patient/NN
with/IN
acute/JJ
promyelocytic/JJ
leukemia/NN
by/IN
RT-PCR/NN
:/:
necessity/NN
of/IN
chemotherapy/NN
following/VBG
ATRA/NN
therapy/NN
./.

The/DT
PML/RAR/NN
alpha/NN
fusion/NN
gene/NN
resulting/VBG
from/IN
the/DT
t (15;17)/NN
translocation/NN
is/VBZ
a/DT
specific/JJ
marker/NN
for/IN
acute/JJ
promyelocytic/JJ
leukemia/NN
(/(
APL/NN
)/)
./.
=====
We/PRP
examined/VBD
bone/NN
marrow/NN
cells/NNS
by/IN
reverse/JJ
transcriptase-polymerase/NN
chain/NN
reaction/NN
(/(
RT-PCR/NN
)/)
to/TO
detect/VB
residual/JJ
PML/RAR/NN
alpha/NN
mRNA-containing/JJ
cells/NNS
following/VBG
treatment/NN
with/IN
all-trans/JJ
retinoic/JJ
acid/NN
(/(
ATRA/NN
)/)
and/CC
cytotoxic/JJ
chemotherapy/NN
in/IN
a/DT
patient/NN
with/IN
APL/NN
./.
=====
This/DT
RT-PCR/NN
assay/NN
can/MD
detect/VB
one/CD
leukemic/JJ
cell/NN
in/IN
10(2)/CD
normal/JJ
cells/NNS
in/FW
vitro/FW
./.
=====
We/PRP
show/VBP
that/IN
PML/RAR/NN
alpha/NN
mRNA/NN
was/VBD
still/RB
detectable/JJ
despite/IN
clinical/JJ
remission/NN
following/VBG
ATRA/NN
treatment/NN
,/,
but/CC
undetectable/JJ
following/VBG
consolidation/NN
with/IN
chemotherapy/NN
./.
=====
These/DT
data/NNS
show/VBP
that/IN
this/DT
technique/NN
is/VBZ
useful/JJ
for/IN
the/DT
identification/NN
of/IN
minimal/JJ
residual/JJ
disease/NN
in/NN
patients/NNS
with/IN
APL/NN
and/CC
that/IN
cytotoxic/JJ
chemotherapy/NN
following/VBG
ATRA/NN
therapy/NN
is/VBZ
required/VBN
for/IN
the/DT
elimination/NN
of/IN
APL/NN
cells/NNS
./.